Innovation1 Biotech (Innovation1 Biotech) Total Stockholders Equity : $-3.43 Mil (As of Aug. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Innovation1 Biotech Total Stockholders Equity?

Innovation1 Biotech's Total Stockholders Equity for the quarter that ended in Aug. 2023 was $-3.43 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Innovation1 Biotech's Book Value per Share for the quarter that ended in Aug. 2023 was $-0.17. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Innovation1 Biotech's Debt-to-Equity for the quarter that ended in Aug. 2023 was -0.07.

Innovation1 Biotech Total Stockholders Equity Historical Data

The historical data trend for Innovation1 Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovation1 Biotech Total Stockholders Equity Chart

Innovation1 Biotech Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Total Stockholders Equity

Get a 7-Day Free Trial

0.03

-2.68

-0.23

2.85

-3.43

Innovation1 Biotech Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Total Stockholders Equity	Get a 7-Day Free Trial															2.85	2.08	1.48	1.25	-3.43

Innovation1 Biotech (OTCPK:IVBT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Innovation1 Biotech's Book Value per Share for the quarter that ended in Aug. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-3.43	-	0.008)	/	20.4702
	=	-0.17

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Innovation1 Biotech's Debt-to-Equity for the quarter that ended in Aug. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.01	+	0.219)	/	-3.43
	=	-0.07

Innovation1 Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Innovation1 Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovation1 Biotech (Innovation1 Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Innovation1 Biotech Inc (OTCPK:IVBT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Wall Street, Suite 2701, New York, NY, USA, 10005

Website

https://www.innovation1bio.com

Innovation1 Biotech Inc is a shell company.

Executives

Grays Peak Llc	10 percent owner	8 THE GREEN, STE. A, DOVER DE 19803
Timothy Orr	director, 10 percent owner, officer: President	4010 TANAGER LANE, #A, MEAD WA 99021
Darren Long	director, 10 percent owner, officer: CEO & Secretary	4010 TANAGER LANE, #A, MEAD WA 99021
Brian Martinho	director, 10 percent owner, officer: Treasurer	4010 EAST TANAGER LANE, MEAD WA 99021